{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-024119","form_type":"8-K","ticker":"PURE","cik":"0001006028","company_name":"PURE BIOSCIENCE, INC.","filed_at":"2023-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.840584+00:00","generated_at":"2026-06-13T10:25:18.073369+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pure Bioscience raises $1.015M via convertible notes from accredited investors","bullets":["Issued convertible promissory notes for $1.015M initial principal; potential subsequent closings up to $1.8M total.","Notes bear 7.55% annual interest, mature in three years, convertible at 30-day VWAP with $0.15 floor and $0.23 cap.","Board members Tom Y. Lee and Ivan Chen invested $1,000,000 and $15,000 respectively.","Notes sold in private placement under Section 4(a)(2); disinterested board approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-024119","json":"https://secwatch.observer/filing/0001493152-23-024119.json","markdown":"https://secwatch.observer/filing/0001493152-23-024119.md","text":"https://secwatch.observer/filing/0001493152-23-024119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006028/000149315223024119/0001493152-23-024119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006028/000149315223024119/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T10:25:18.073369+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"128486a268072817fd2ef6b6b547dbbd195f6861","claim":"PURE BIOSCIENCE, INC. incurred convertible notes of $1,015,000 at 7.55% maturing third-year anniversary of the date of issuance.","evidence_excerpt":"On July 3, 2023, Pure Bioscience, Inc. (the “Company”) entered into a Note Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (“Lenders”) pursuant to which the Company issued the Lenders convertible promissory notes (the “Notes”, collectively with the Note Purchase Agreement, the “Notes Documents”) with an aggregate principal balance of $1,015,000 (the “Private Placement”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315223024119/0001493152-23-024119-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$1,015,000"},{"label":"Rate","value":"7.55%"},{"label":"Maturity","value":"third-year anniversary of the date of issuance"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"146e41c2ea4c469e0e3f82a1952d7a480ca44335","claim":"PURE BIOSCIENCE, INC. entered into Note Purchase Agreement with certain accredited investors valued at $1,015,000 (effective 2023-07-03).","evidence_excerpt":"On July 3, 2023, Pure Bioscience, Inc. (the “Company”) entered into a Note Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (“Lenders”) pursuant to which the Company issued the Lenders convertible promissory notes (the “Notes”, collectively with the Note Purchase Agreement, the “Notes Documents”) with an aggregate principal balance of $1,015,000 (the “Private Placement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315223024119/0001493152-23-024119-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"$1,015,000"},{"label":"Effective","value":"2023-07-03"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}